Chlorpromazine activates p21(Waf1/Cip1) gene transcription via early growth response-1 (Egr-1) in C6 glioma cells.
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3858/emm.2010.42.5.041
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Soon Young SHIN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Chang Gun KIM
			        		
			        		;
		        		
		        		
		        		
			        		Se Hyun KIM
			        		
			        		;
		        		
		        		
		        		
			        		Yong Sik KIM
			        		
			        		;
		        		
		        		
		        		
			        		Yoongho LIM
			        		
			        		;
		        		
		        		
		        		
			        		Young Han LEE
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Institute of Biomedical Science and Technology, Konkuk University Hospital, Seoul 143-729, Korea. yhlee58@konkuk.ac.kr
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		chlorpromazine;
			        		
			        		
			        		
				        		c-Jun N-terminal kinase;
			        		
			        		
			        		
				        		cyclin-dependent kinase inhibitor p21;
			        		
			        		
			        		
				        		early growth response-1;
			        		
			        		
			        		
				        		extracellular signal-regulated kinase;
			        		
			        		
			        		
				        		tumor suppressor protein p53
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:Experimental & Molecular Medicine
	            		
	            		 2010;42(5):395-405
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	2-Chloro-10-[3(-dimethylamino)propyl]phenothiazinemonohydrochloride (chlorpromazine) is a phenothiazine derivative used clinically to control psychotic disorders. It also exhibits an anticancer activity. Treatment with chlorpromazine (CPZ) results in cell-cycle arrest at the G2/M phase in rat C6 glioma cells. CPZ reduces the expression of cell cycle-related proteins, such as cyclin D1, cyclin A, and cyclin B1, but causes an increase in the p21(Waf1/Cip1) level. The molecular mechanism by which CPZ regulates p21(Waf1/Cip1) expression is unknown. Here, we provide evidence that CPZ activates the p21(Waf1/Cip1) gene promoter via induction of the transcription factor early growth response-1 (Egr-1) independently of p53 in C6 cells. A point mutation in the Egr-1-binding motif within the p21(Waf1/Cip1) promoter abrogated promoter inducibility due to CPZ. Forced expression of Egr-1 enhanced p21(Waf1/Cip1) promoter activity. In contrast, knockdown of endogenous Egr-1 by small interference RNA attenuated CPZ-induced p21(Waf1/Cip1) promoter activity. A chromatin immunoprecipitation assay demonstrated that Egr-1 binds to the p21(Waf1/Cip1) gene promoter. Further analysis showed that the ERK and JNK MAP kinases are required for induction of Egr-1 by CPZ. Finally, stable silencing of Egr-1 expression lead to attenuated CPZ-inducible p21(Waf1/Cip1) expression and inhibited G2/M phase cell-cycle arrest. These results demonstrate that a functional link between ERK and JNK MAP kinase pathways and p21(Waf1/Cip1) induction via Egr-1 contributes to CPZ-induced anticancer activity in C6 glioma cells.